Concord Biotech Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
- Paid Up Capital ₹ 10.46 Cr
- Company Age 40 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 155.00 Cr
- Satisfied Charges ₹ 44.77 Cr
- Revenue Growth 16.79%
- Profit Growth -24.12%
- Ebitda -16.46%
- Net Worth 10.75%
- Total Assets 11.04%
About Concord Biotech
Concord Biotech Limited (CBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 23 November 1984 and has a history of 40 years and three months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Servomed Pharmaceuticals Limited. The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.46 Cr.
The company currently has active open charges totaling ₹155.00 Cr. The company has closed loans amounting to ₹44.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Concord Biotech Limited India are Prakash Sajnani as COMPANY SECRETARY and Lalit Sethi serving as the Chief Financial Officer (CFO). Ravi Kapoor, Amitabh Thakore, Utpal Sheth, and Seven other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ1984PLC007440
- Company No.
007440
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Nov 1984
- Date of AGM
07 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc-Ahmedabad
Industry
Who are the key members and board of directors at Concord Biotech?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Sajnani  | Company Secretary | 15-Feb-2004 | Current |
| Lalit Sethi | CFO(Kmp) | 14-Mar-2022 | Current |
| Ankur Vaid | Managing Director | 04-Dec-2009 | Current |
| Sudhir Vaid | Managing Director | 14-Feb-2011 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Utpal Sheth | Director | 04-Dec-2009 | Current |
| Ravi Kapoor | Director | 15-Dec-2003 | Current |
| Rajiv Agarwal | Director | 30-Jun-2008 | Current |
| Amitabh Thakore | Director | 31-Jan-2017 | Current |
| Arvind Agarwal | Director | 24-May-2022 | Current |
| Jayaram Easwaran | Director | 14-Jun-2022 | Current |
Financial Performance of Concord Biotech.
Concord Biotech Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.79% increase. The company also saw a substantial fall in profitability, with a 24.12% decrease in profit. The company's net worth Soared by an impressive increase of 10.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Concord Biotech?
In 2022, Concord Biotech had a promoter holding of 44.11% and a public holding of 55.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Klj Plasticizers Limited.Arvind Agarwal is a mutual person
Inventurus Knowledge Solutions LimitedUtpal Sheth is a mutual person
Snv Aviation Private LimitedUtpal Sheth is a mutual person
Kabra Extrusion Technik LtdUtpal Sheth is a mutual person
Hiranandani Financial Services Private LimitedUtpal Sheth is a mutual person
Jindal Stainless LimitedJayaram Easwaran is a mutual person
Charges (Loans)
₹155.00 Cr
₹44.77 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 110.00 Cr
- Axis Bank Limited : 45.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2019 | State Bank Of India | ₹110.00 Cr | Open |
| 27 Jan 2003 | Axis Bank Limited | ₹45.00 Cr | Open |
| 11 Aug 2015 | Citi Bank N.A. | ₹30.82 Cr | Satisfied |
| 09 Dec 2014 | Citi Bank N.A. | ₹10.00 Cr | Satisfied |
| 23 Jan 2012 | Citibank N. A. | ₹3.70 Cr | Satisfied |
How Many Employees Work at Concord Biotech?
Concord Biotech has a workforce of 1327 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Concord Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
